Point72 Asset Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.7M | Sell |
1,904,214
-38,148
| -2% | -$354K | 0.03% | 451 |
|
|
2025
Q1 | $14.2M | Sell |
1,942,362
-993,562
| -34% | -$7.28M | 0.03% | 448 |
|
|
2024
Q4 | $25.1M | Buy |
2,935,924
+895,304
| +44% | +$7.65M | 0.06% | 345 |
|
|
2024
Q3 | $17.8M | Sell |
2,040,620
-666,043
| -25% | -$5.79M | 0.05% | 379 |
|
|
2024
Q2 | $18.5M | Buy |
+2,706,663
| New | +$18.5M | 0.05% | 371 |
|
|
2022
Q4 | – | Sell |
-1,000
| Closed | -$4K | – | 1334 |
|
|
2022
Q3 | $4K | Sell |
1,000
-49,000
| -98% | -$196K | ﹤0.01% | 986 |
|
|
2022
Q2 | $201K | Buy |
+50,000
| New | +$201K | ﹤0.01% | 947 |
|